Last year Braxia acquired Tassili for clinical research. Tassili has a collaborative research agreement with the University of Miami’s Miller School of Medicine. The agreement covers dosing rats and mice who have been afflicted with a post-traumatic stress disorder or traumatic brain injury with PTSD a combination of psilocybin and CBD. The objective of the Tassili pre-clinical trials is to assess how the combination of psilocybin and CBD may mitigate the adverse effects of PTSD and a traumatic brain injury with PTSD.
Braxia also purchased the biotech company Altmed last year.
The transaction gave Braxia three trials in the Phase I stage and three trials in the preclinical stage during 2020, as well as seven patents for its ketamine/psilocybin delivery platforms and formulations.
Braxia acquired the biotech company Novo Formulations in March 2020 for IP development. Novo’s IP’s scope focuses on novel and innovative delivery systems for the pharmaceutical industry. Novo is actively formulating and developing bioavailable, delivery platforms, including topical creams, intranasal spray, and sublingual tabs.
Novo is also developing an intranasal formulation of racemic ketamine for the treatment of depression and pain. Chemical and analytic stability tests are being conducted at McMaster University. The project is set to be completed sometime later this year.
If they are the first to show ketamines successful use for a new disease (Suicide, TRD, PTSD or Bipolar D) in a Phase 3 Clinical Trial or sell it after Phase 2 to big pharma they get 3 year of exclusive rights by the FDA!
"A brand-name drug with an active ingredient that has been approved before may be awarded a three-year exclusivity in certain circumstances, such as if a new way of delivering the active ingredient is proposed (for example, a tablet rather than a liquid) or a different disease or condition the drug can treat is identified. To get this approval, the drug company must conduct new clinical studies in humans*."*
https://www.fda.gov/media/111069/download